Veru (VERU) Competitors $0.53 +0.00 (+0.91%) As of 02:31 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERU vs. NUS, NATR, MED, EL, PBH, IPAR, HLF, USNA, STOK, and ORICShould you be buying Veru stock or one of its competitors? The main competitors of Veru include Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Estée Lauder Companies (EL), Prestige Consumer Healthcare (PBH), Inter Parfums (IPAR), Herbalife (HLF), USANA Health Sciences (USNA), Stoke Therapeutics (STOK), and ORIC Pharmaceuticals (ORIC). Veru vs. Nu Skin Enterprises Nature's Sunshine Products Medifast Estée Lauder Companies Prestige Consumer Healthcare Inter Parfums Herbalife USANA Health Sciences Stoke Therapeutics ORIC Pharmaceuticals Veru (NASDAQ:VERU) and Nu Skin Enterprises (NYSE:NUS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, community ranking, valuation, risk, institutional ownership and earnings. Do analysts rate VERU or NUS? Veru currently has a consensus target price of $4.33, suggesting a potential upside of 717.61%. Nu Skin Enterprises has a consensus target price of $6.88, suggesting a potential upside of 23.10%. Given Veru's stronger consensus rating and higher probable upside, analysts clearly believe Veru is more favorable than Nu Skin Enterprises.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veru 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Nu Skin Enterprises 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals and insiders believe in VERU or NUS? 47.2% of Veru shares are held by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are held by institutional investors. 14.9% of Veru shares are held by insiders. Comparatively, 1.7% of Nu Skin Enterprises shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, VERU or NUS? Veru has a beta of -0.69, meaning that its stock price is 169% less volatile than the S&P 500. Comparatively, Nu Skin Enterprises has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500. Is VERU or NUS more profitable? Nu Skin Enterprises has a net margin of -8.46% compared to Veru's net margin of -223.85%. Nu Skin Enterprises' return on equity of 5.86% beat Veru's return on equity.Company Net Margins Return on Equity Return on Assets Veru-223.85% -112.75% -67.54% Nu Skin Enterprises -8.46%5.86%2.62% Does the media favor VERU or NUS? In the previous week, Nu Skin Enterprises had 3 more articles in the media than Veru. MarketBeat recorded 4 mentions for Nu Skin Enterprises and 1 mentions for Veru. Nu Skin Enterprises' average media sentiment score of 1.25 beat Veru's score of 0.94 indicating that Nu Skin Enterprises is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veru 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nu Skin Enterprises 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, VERU or NUS? Veru has higher earnings, but lower revenue than Nu Skin Enterprises. Veru is trading at a lower price-to-earnings ratio than Nu Skin Enterprises, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeru$16.89M4.59-$37.80M-$0.26-2.04Nu Skin Enterprises$1.73B0.16-$146.59M-$2.95-1.89 Does the MarketBeat Community believe in VERU or NUS? Nu Skin Enterprises received 240 more outperform votes than Veru when rated by MarketBeat users. However, 69.82% of users gave Veru an outperform vote while only 63.81% of users gave Nu Skin Enterprises an outperform vote. CompanyUnderperformOutperformVeruOutperform Votes27369.82% Underperform Votes11830.18% Nu Skin EnterprisesOutperform Votes51363.81% Underperform Votes29136.19% SummaryNu Skin Enterprises beats Veru on 10 of the 18 factors compared between the two stocks. Remove Ads Get Veru News Delivered to You Automatically Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERU vs. The Competition Export to ExcelMetricVeruPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$77.44M$6.48B$5.29B$7.37BDividend YieldN/A3.24%5.11%4.31%P/E Ratio-2.036.8321.7017.78Price / Sales4.59228.36378.1494.74Price / CashN/A65.6738.1534.64Price / Book2.945.876.423.98Net Income-$37.80M$142.26M$3.20B$247.33M7 Day Performance1.05%7.58%4.73%4.31%1 Month Performance6.85%-14.16%-9.88%-7.80%1 Year Performance-54.31%-9.81%10.77%1.40% Veru Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VERUVeru1.9572 of 5 stars$0.53+0.9%$4.33+717.6%-58.2%$77.44M$16.89M-2.03230News CoverageNUSNu Skin Enterprises3.6921 of 5 stars$6.22-3.4%$6.88+10.5%-54.1%$309.33M$1.73B-2.113,700Gap DownNATRNature's Sunshine Products3.5292 of 5 stars$11.47-2.6%$19.00+65.6%-37.2%$212.01M$454.36M13.03850Analyst UpgradeShort Interest ↓News CoverageGap DownMEDMedifast3.8213 of 5 stars$13.01-1.4%$16.50+26.9%-62.3%$142.25M$602.46M72.25870Positive NewsELEstée Lauder Companies4.7547 of 5 stars$52.98+0.1%$86.00+62.3%-61.5%$19.02B$15.18B-27.1763,000Analyst ForecastPBHPrestige Consumer Healthcare4.1553 of 5 stars$81.41-1.7%$93.33+14.6%+17.4%$4.03B$1.12B19.07540News CoveragePositive NewsHigh Trading VolumeIPARInter Parfums3.9444 of 5 stars$103.21-0.9%$162.80+57.7%-18.1%$3.32B$1.45B22.15530Short Interest ↑Positive NewsHLFHerbalife4.3378 of 5 stars$7.78-6.0%$12.00+54.3%-23.5%$788.03M$4.99B3.1210,100Positive NewsUSNAUSANA Health Sciences4.7869 of 5 stars$24.69-3.1%$36.00+45.8%-45.5%$466.84M$854.50M8.731,900Upcoming EarningsSTOKStoke Therapeutics3.2597 of 5 stars$6.01+1.1%$24.67+310.8%-39.3%$324.74M$36.56M-2.86100Analyst RevisionORICORIC Pharmaceuticals3.479 of 5 stars$4.55-6.8%$18.86+314.4%-50.4%$323.17MN/A-2.5080 Remove Ads Related Companies and Tools Related Companies NUS Alternatives NATR Alternatives MED Alternatives EL Alternatives PBH Alternatives IPAR Alternatives HLF Alternatives USNA Alternatives STOK Alternatives ORIC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VERU) was last updated on 4/17/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veru Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veru With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.